Influence of Non-Hormonal Intervention On Lipid Profile Among Perimenopausal Women.
Life Sciences -Nursing
DOI:
https://doi.org/10.22376/ijlpr.2023.13.5.L260-L266Keywords:
Soya chunk, estrogen, perimenopausal women, HDL, LDL, TCL, Dyslipidemia, non-hormonal therapy.Abstract
This study aims to find the effect of a non-hormonal therapy to help solve dyslipidemia among perimenopausalwomen. The objective of achieving this aim was to find the effect of soya supplementation on low-density lipoprotein (LDL),high-density lipoprotein (HDL), and total cholesterol (TCL) levels among perimenopausal women with dyslipidemia. This singleblindedquasi-experimental study was conducted in a rural community in southern India with 54 perimenopausal women in 40-55 age. The subjects were randomized into a control group that received only structured health education and an experimentalgroup that received structured health education, and soya supplements 50 grams of soya meal curry on alternative days for 3days a week for 16 weeks. The three-outcome analysis for the study HDL, LDL, and TCL levels was analyzed as a part ofbaseline selection criteria (Pre-test), following 8 weeks (Post-test 1) and 16th weeks (Post-test 2), respectively. The study resultsshowed that all three biomarkers normalized significantly better in the experimental group than in the control group. The studysupports the statement that a soya diet can be an adjunct to estrogen therapy. Hence, the study favors using a soya diet as atreatment choice for managing dyslipidemia among perimenopausal women.
References
Guthrie JR, Dennerstein L, Taffe JR, Donnelly V. Health care-seeking for menopausal problems. Climacteric. 2003;6(2):112-7. doi: 10.1080/cmt.6.2.112.117, PMID 12841881.
Sharman Moser S, Chodick G, Bar-On S, Shalev V. Healthcare utilization and prevalence of symptoms in women with menopause: A real-world analysis. Int J Womens Health. 2020;12:445-54. doi: 10.2147/IJWH.S246113, PMID 32606996.
Jin X, Lin Z, Liu Y, Lin L, Zhu B. Hormone replacement therapy benefits Meibomian gland dysfunction in perimenopausal women. Med (Baltim). 2016;95(31):e4268. doi: 10.1097/MD.0000000000004268, PMID 27495030.
Li S, Ma L, Song Y, Zheng J, Cai Y, Xu H, et al. Effects of hormone replacement therapy on glucose and lipid metabolism in peri- and postmenopausal women with a history of menstrual disorders. BMC Endocr Disord. 2021;21(1):121. doi: 10.1186/s12902-021-00784-9, PMID 34130678.
Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ. 2020;371:m3873. doi: 10.1136/bmj.m3873, PMID 33115755.
Kim HR, Yang HM. Facilitators and inhibitors of lifestyle modification and maintenance of Korean postmenopausal women: revealing conversations from FOCUS group interview. Int J Environ Res Public Health. 2020;17(21):8178. doi: 10.3390/ijerph17218178, PMID 33167466.
Karanth L, Chuni N, Nair NS. Antidepressants for menopausal symptoms. Cochrane Database of Systematic Reviews. Published online September 12, 2019. doi: 10.1002/14651858.CD013417.
Krause M, Wheeler TL, Snyder TE, Richter HE. Local effects of vaginally administered estrogen therapy: a review. J Pelvic Med Surg. 2009;15(3):105-14. doi: 10.1097/SPV.0b013e3181ab4804, PMID 22229022.
Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Crandall CJ, Shifren JL, et al. Vaginal estrogen use and chronic disease risk in the Nurses’ Health Study. Menopause N Y N. 2018;26(6):603-610. 2018;26(6):603-10. doi: 10.1097/GME.0000000000001284, PMID 30562320.
Kirshner S, Weiss PL, Tirosh E. Meal-Maker: a virtual meal preparation environment for children with cerebral palsy. Eur J Spec Needs Educ. 2011;26(3):323-36. doi: 10.1080/08856257.2011.593826.
Qin P, Wang T, Luo Y. A review on plant-based proteins from soybeaHealth benefits and soy product development. J Agric Food Res. 2022;7:100265. doi: 10.1016/j.jafr.2021.100265.
Rizzo G, Baroni L. Soy, Soy foods and their role in vegetarian diets. Nutrients. 2018;10(1):43. doi: 10.3390/nu10010043, PMID 29304010.
Jenkins DJA, Mirrahimi A, Srichaikul K, Berryman CE, Wang L, Carleton A, et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr. 2010;140(12):2302S-11S. doi: 10.3945/jn.110.124958, PMID 20943954.
Welty FK. Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk. Curr Opin Lipidol. 2020;31(4):206-31. doi: 10.1097/MOL.0000000000000689, PMID 32692035.
Inaraja V, Thuissard I, Andreu-Vazquez C, Jodar E. Lipid profile changes during the menopausal transition. Menopause N Y N. 2020;27(7):780-787. 2020;27(7):780-7. doi: 10.1097/GME.0000000000001532, PMID 32187130.
Mesalić L, Tupković E, Kendić S, Balić D. Correlation between hormonal and lipid status in women in menopause. Bosn J Basic Med Sci. 2008;8(2):188-92. doi: 10.17305/bjbms.2008.2980, PMID 18498273.
Kunutsor SK, Zaccardi F, Karppi J, Kurl S, Laukkanen JA. Is high serum LDL/HDL cholesterol ratio an emerging risk factor for sudden cardiac death? Findings from the KIHD study. J Atheroscler Thromb. 2017;24(6):600-8. doi: 10.5551/jat.37184, PMID 27784848.
Phan BAP, Toth PP. Dyslipidemia in women: etiology and management. Int J Womens Health. 2014;6:185-94. doi: 10.2147/IJWH.S38133, PMID 24532973.
Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. BioMed Res Int. 2014;2014:757461. doi: 10.1155/2014/757461, PMID 24734243.
Schmidt M, Arjomand-Wölkart K, Birkhäuser MH, Genazzani AR, Gruber DM, Huber J, et al. Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints. Gynecol Endocrinol. 2016;32(6):427-30. doi: 10.3109/09513590.2016.1152240, PMID 26943176.
Desmawati D, Sulastri D. Phytoestrogens and their health effect. Open Access Maced J Med Sci. 2019;7(3):495-9. doi: 10.3889/oamjms.2019.044, PMID 30834024.
Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J. 2008;7:17. doi: 10.1186/1475-2891-7-17, PMID 18522734.
Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De Ponti F. Phytoestrogens in postmenopause: state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem. 2014;21(4):417-36. doi: 10.2174/09298673113206660297, PMID 24164197.
Cianci A, Colacurci N, Paoletti AM, Perino A, Cicinelli E, Maffei S, et al. Soy isoflavones, inulin, calcium, and vitamin D3 in post-menopausal hot flushes: an observational study. Clin Exp Obstet Gynecol. 2015;42(6):743-5. doi: 10.12891/ceog2008.2015, PMID 26753476.
Chen LR, Ko NY, Chen KH. Isoflavone supplements for menopausal women: A systematic review. Nutrients. 2019;11(11):2649. doi: 10.3390/nu11112649, PMID 31689947.
Chen MN, Lin CC, Liu CF. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric. 2015;18(2):260-9. doi: 10.3109/13697137.2014.966241, PMID 25263312.
Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause. 2007;14(3 Pt 1):468-73. doi: 10.1097/GME.0b013e31802cc7d0, PMID 17290160.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Muthulakshmi. C, Dr. S. Kalabarathi, Dr. Nithisharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.